IP Library Granted Patent US 6,869,608
Granted Patent B2
US 6,869,608 · App. 10/000,321 · Granted Mar 22, 2005

Peptides derived from a retrovirus of the HIV group and their use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,869,608
App. No.
10/000,321
Granted
Mar 22, 2005
Kind
B2
Abstract

Immunologically active peptides which are derived from a novel immunodeficiency virus which has the designation MVP5180/91 are described. A diagnostic containing such a peptide and methods of detecting an antibody against a retrovirus that causes immune deficiency using such diagnostic composition are also described. A kit containing the immunologically active peptides is also described. An immunogen and method of immunizing a mammal against HIV infection using the immunologically active peptides is described. DNA encoding the peptides and methods of detecting nucleic acids encoding HIV viruses are also described.

Claims (14)

1. An immunologically active peptide consisting of a fragment of the following amino acid sequence:

VWGIRQLRARLQALETLIQNQQRLNLWGXKGKLIXYTSVKWNTSWSGR (SEQ ID NO: 1) wherein said fragment has at least 15 consecutive amino acid residues of SEQ ID NO: 1 and wherein X is C or S.

2. The peptide of claim 1 , wherein said at least 15 consecutive amino acids are selected from the amino acids in the following amino acid sequence:

RLQALETLIQNQQRLNLWGXKGKLIXYTSVKWN (Residues 10-42 of SEQ ID NO: 1) wherein X is C or S.

3. The peptide of claim 1 which binds antibodies against HIV-1 subtype 0 virus.

4. The peptide of claim 1 , wherein said fragment has from 20 to 30 consecutive amino acids of SEQ ID NO:1.

5. The peptide of claim 1 which further comprises, at one or both ends of the peptide, one or more sequences of amino acids, wherein said sequences are not taken from the amino acid sequence of the retrovirus MVP5180/91.

6. The peptide of claim 1 , wherein X is C.

7. The peptide of claim 6 , wherein C represents a cysteine residue in an oxidized state.

8. The peptide of claim 6 , consisting of the amino acid sequence RLQALETLIQNQQRLNLWGCKGKLIC (SEQ ID NO: 3).

9. The peptide of claim 8 , wherein C represents a cysteine residue in an oxidized state.

10. The peptide of claim 6 consisting of the amino acid sequence NQQRLNLWGCKGKLICYTSVKWN (SEQ ID NO: 2).

11. The peptide of claim 10 , wherein C represents a cysteine residue in an oxidized state.

12. The peptide of claim 1 consisting of the amino acid sequence RLQALETLIQNQQRLNLWGSKGKLIS (SEQ ID NO: 4).

Assignments (1)
CHANGE OF NAME Recorded Feb 26, 2009
From: DADE BEHRING MARBURG GMBH
To: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Reel/Frame 022309/0627 →